SCHEMBL30597679

SCHEMBL30597679

O=C1C(c2c(O)[nH]c3cc(F)ccc23)=Nc2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 16/20 1.00
GSK3B P49841 16/20 1.00
CDK5 Q00535 13/20 1.00
CDK5R1 Q15078 13/20 1.00
CDK1 P06493 9/20 1.00
CCNB2 O95067 8/20 1.00
CCNB1 P14635 8/20 1.00
CCNB3 Q8WWL7 8/20 1.00
FLT3 P36888 6/20 0.82
CDK2 P24941 3/20 0.73
CCNE1 P24864 2/20 0.73
CDK4 P11802 2/20 0.73
CCNA2 P20248 2/20 0.73
CCND1 P24385 2/20 0.73
MEN1 O00255 1/20 0.73
CDK14 O94921 1/20 0.73
MAPT P10636 1/20 0.73
SRC P12931 1/20 0.73
CTRB1 P17538 1/20 0.73
CDK11B P21127 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30597674 0.85 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CDK1
SCHEMBL30094663 0.85 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CDK1
SCHEMBL30319807 0.85 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CDK1
SCHEMBL29421607 0.84 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CDK1
SCHEMBL30597663 0.82 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CDK1
SCHEMBL29648491 0.78 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CDK1
SCHEMBL30273058 0.78 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CDK1
SCHEMBL30597665 0.78 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CDK1
SCHEMBL30319763 0.77 GSK3A (1.00) GSK3AGSK3BCDK5CDK5R1CDK1
SCHEMBL30380971 0.77 GSK3A (0.70) GSK3AGSK3BCDK5CDK5R1CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4466342-A1 METHOD FOR REPROGRAMMING CD8+ T CELLS TO ENHANCE THEIR THERAPEUTIC POTENTIAL AND APPLICATIONS THEREOF Institut Pasteur (FR) 2024-11-27 EP disclosed
WO-2023139242-A1 METHOD FOR REPROGRAMMING CD8+ T CELLS TO ENHANCE THEIR THERAPEUTIC POTENTIAL AND APPLICATIONS THEREOF INSTITUT PASTEUR (FR) 2023-07-27 WO disclosed